Getting the Deal Done: Assessing Transactional Risk from Antitrust and Insurance Perspectives


Healthcare transactions of all shapes and sizes continue to be in the antitrust cross-hairs as the Federal Trade Commission (“FTC”) and Department of Justice, Antitrust Division (“DOJ”) closely scrutinize combinations of hospitals, physicians, and payors, as well as the formation of provider networks that clinically or financially integrate their members of clinically or financial integrated providers networks.

Even small deals, such as “roll ups” of practices by private equity firms are increasingly subject to government investigations that can delay or even prevent such deals from closing.

Moreover, for parties involved in transactions, understanding the key market trends affecting Representations and Warranties Insurance (RWI) can affect your alignment strategy.

Our panelists will dive into these issues from legal and commercial insurance perspectives to provide practical takeaways for providers, payors, and investors in the healthcare industry. 


Practice Areas


Jump to Page

By scrolling this page, clicking a link or continuing to browse our website, you consent to our use of cookies as described in our Cookie and Advertising Policy. If you do not wish to accept cookies from our website, or would like to stop cookies being stored on your device in the future, you can find out more and adjust your preferences here.